Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action
- 3 October 2022
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 185, 106481
Abstract
No abstract availableKeywords
Funding Information
- Beijing Municipal Health Commission (YWJKJJHKYJJ-B20645FN)
- Beijing Medical and Health Foundation
- Chengdu University of Traditional Chinese Medicine (21-Y17)
This publication has 110 references indexed in Scilit:
- The C-terminus region of β-arrestin1 modulates VE-cadherin expression and endothelial cell permeabilityCell Communication and Signaling, 2013
- Cyclooxygenase-2 in the kidney: good, BAD, or both?Kidney International, 2011
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory networkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditureCurrent Opinion in Lipidology, 2009
- Efficacy of berberine in patients with type 2 diabetes mellitusMetabolism, 2008
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2008
- Enhanced TLR-mediated NF-IL6–dependent gene expression by Trib1 deficiencyJournal of Experimental Medicine, 2007
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1αProceedings of the National Academy of Sciences, 2007
- Sphingosine 1‐phosphate as a regulator of osteoclast differentiation and osteoclast–osteoblast couplingThe EMBO Journal, 2006